These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 31144209)

  • 21. The role of complement in mAb-based therapies of cancer.
    Taylor RP; Lindorfer MA
    Methods; 2014 Jan; 65(1):18-27. PubMed ID: 23886909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Assessment of total complement activity of blood plasma (serum) using reader for immunoenzyme analysis].
    Kuznetsov SI; Tarasova AV
    Klin Lab Diagn; 1995; (4):41-3. PubMed ID: 7670822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High dose intravenous immunoglobulin does not affect complement-bacteria interactions.
    Wagner E; Platt JL; Frank MM
    J Immunol; 1998 Feb; 160(4):1936-43. PubMed ID: 9469456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The phylogeny of the complement system and the origins of the classical pathway.
    Dodds AW; Matsushita M
    Immunobiology; 2007; 212(4-5):233-43. PubMed ID: 17544809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum.
    Banda NK; Mehta G; Chao Y; Wang G; Inturi S; Fossati-Jimack L; Botto M; Wu L; Moghimi SM; Simberg D
    Part Fibre Toxicol; 2014 Nov; 11():64. PubMed ID: 25425420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics.
    Felberg A; Urban A; Borowska A; Stasiłojć G; Taszner M; Hellmann A; Blom AM; Okrój M
    Cancer Immunol Immunother; 2019 Apr; 68(4):587-598. PubMed ID: 30725204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.
    Quast I; Keller CW; Maurer MA; Giddens JP; Tackenberg B; Wang LX; Münz C; Nimmerjahn F; Dalakas MC; Lünemann JD
    J Clin Invest; 2015 Nov; 125(11):4160-70. PubMed ID: 26436649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alternative complement activation pathway. Its mechanism, importance and quantitative determination].
    Gancevici GG; Popescu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(3):209-21. PubMed ID: 6390651
    [No Abstract]   [Full Text] [Related]  

  • 29. The C-type lectin of the aggrecan G3 domain activates complement.
    Melin Fürst C; Mörgelin M; Vadstrup K; Heinegård D; Aspberg A; Blom AM
    PLoS One; 2013; 8(4):e61407. PubMed ID: 23596522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement function in mAb-mediated cancer immunotherapy.
    Gelderman KA; Tomlinson S; Ross GD; Gorter A
    Trends Immunol; 2004 Mar; 25(3):158-64. PubMed ID: 15036044
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of human IgA antibodies on complement-dependent cytotoxicity mediated by combinations of EGF-R-directed antibodies.
    Lohse S; Peipp M; Beyer T; Valerius T; Dechant M
    Arch Immunol Ther Exp (Warsz); 2010 Aug; 58(4):303-12. PubMed ID: 20508996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional assessment in vitro of human-complement-dependent antibody-induced cytotoxicity of neoplastic cells.
    Brezicka F; Einbeigi Z; Bergman B
    Cancer Immunol Immunother; 2000 Jul; 49(4-5):235-42. PubMed ID: 10941906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The complement system in systemic autoimmune disease.
    Chen M; Daha MR; Kallenberg CG
    J Autoimmun; 2010 May; 34(3):J276-86. PubMed ID: 20005073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering.
    Oostindie SC; van der Horst HJ; Lindorfer MA; Cook EM; Tupitza JC; Zent CS; Burack R; VanDerMeid KR; Strumane K; Chamuleau MED; Mutis T; de Jong RN; Schuurman J; Breij ECW; Beurskens FJ; Parren PWHI; Taylor RP
    Haematologica; 2019 Sep; 104(9):1841-1852. PubMed ID: 30792198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic inhibition of the early phase of complement activation.
    Roos A; Ramwadhdoebé TH; Nauta AJ; Hack CE; Daha MR
    Immunobiology; 2002 Sep; 205(4-5):595-609. PubMed ID: 12396018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement cascade in systemic lupus erythematosus: analyses of the three activation pathways.
    Ceribelli A; Andreoli L; Cavazzana I; Franceschini F; Radice A; Rimoldi L; Sinico RA; Carlsson M; Wieslander J; Tincani A
    Ann N Y Acad Sci; 2009 Sep; 1173():427-34. PubMed ID: 19758182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-shed antigen CA125 blocks complement-mediated killing via suppression of C1q-antibody binding.
    Kline JB; Fernando S; Ross EN; Grasso L; Nicolaides NC
    Eur J Immunol; 2018 Nov; 48(11):1872-1882. PubMed ID: 30144039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbamylation reduces the capacity of IgG for hexamerization and complement activation.
    Lubbers R; Oostindie SC; Dijkstra DJ; Parren PWHI; Verheul MK; Abendstein L; Sharp TH; de Ru A; Janssen GMC; van Veelen PA; van den Bremer ETJ; Bleijlevens B; de Kreuk BJ; Beurskens FJ; Trouw LA
    Clin Exp Immunol; 2020 Apr; 200(1):1-11. PubMed ID: 31853959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A complement-dependent cytotoxicity-enhancing anti-CD20 antibody mediating potent antitumor activity in the humanized NOD/Shi-scid, IL-2Rγ(null) mouse lymphoma model.
    Sato F; Ito A; Ishida T; Mori F; Takino H; Inagaki A; Ri M; Kusumoto S; Komatsu H; Iida S; Okada N; Inagaki H; Ueda R
    Cancer Immunol Immunother; 2010 Dec; 59(12):1791-800. PubMed ID: 20714721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae.
    Ram S; Shaughnessy J; DeOliveira RB; Lewis LA; Gulati S; Rice PA
    Immunobiology; 2016 Oct; 221(10):1110-23. PubMed ID: 27297292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.